Extract from the Register of European Patents

EP Citations: EP3763716

Cited inSearch
Type:Patent literature
Publication No.:WO2009147125  [Y]
 (BOEHRINGER INGELHEIM INT [DE], et al) [Y] 1-10 * title, abstract; claims 5-8 *;
Type:Patent literature
Publication No.:CN101817833  [XY]
 (JIANGSU CHIATAI TIANQING PHARMACEUTICAL LTD, et al) [X] 1-10 * [0080], compound 1, and [0097], compound 2 * [Y] 1-10;
Type:Patent literature
Publication No.:WO2011118976  [Y]
 (DONG A PHARM CO LTD [KR], et al) [Y] 1-10 * [0075]; Fig. 10 *;
Type:Patent literature
Publication No.:US2012121530  [Y]
 (KLEIN THOMAS [DE], et al) [Y] 1-10 * [0163], [0338]; claim 4 *;
Type:Patent literature
Publication No.:WO2013078765  [XY]
 (SHANGHAI INST MATERIA MEDICA [CN]) [X] 1-10 * compounds 1-144 in table at p. 12 ff.; [0036]; [0395] * [Y] 1-10;
Type:Patent literature
Publication No.:US2016354380  [Y]
 (DUGI KLAUS [GB], et al) [Y] 1-10 * [0071]; example 19; cl. 22 *;
Type:Patent literature
Publication No.:CA3018800  [XY]
 (SHANGHAI INST MATERIA MEDICA CAS [CN]) [X] 1-10 * [0001], [0009], [0020] * [Y] 1-10;
Type:Non-patent literature
Publication information:[XY]  - DENG J ET AL, "The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, vol. 46, no. 1, ISSN 0223-5234, (20110101), pages 71 - 76, (20101218), XP027565690 [X] 1-10 * scheme 1, compound 10d; title, abstract * [Y] 1-10
Type:Non-patent literature
Publication information:[Y]  - KAJI KOSUKE ET AL, "Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats", JOURNAL OF GASTROENTERLOGY, SPRINGER JAPAN KK, JP, vol. 49, no. 3, doi:10.1007/S00535-013-0783-4, ISSN 0944-1174, (20130312), pages 481 - 491, (20130312), XP035346264 [Y] 1-10 * title, abstract *
DOI: http://dx.doi.org/10.1007/s00535-013-0783-4
Type:Non-patent literature
Publication information:[Y]  - MARQUES ANA PATRÍCIA ET AL, "Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice", BIOCHIMICA ET BIOPHYSICA ACTA, ELSEVIER, AMSTERDAM, NL, (20171222), vol. 1862, no. 3, doi:10.1016/J.BBAGEN.2017.11.012, ISSN 0304-4165, pages 403 - 413, XP085414871 [Y] 1-10 * title, abstract, Fig. 3 *
DOI: http://dx.doi.org/10.1016/j.bbagen.2017.11.012
Type:Non-patent literature
Publication information:[Y]  - Fatma A. Mahmoud ET AL, "The Beneficial Effects of Sitagliptin, a Dipeptedyl Peptidase-4 (DPP-4) Inhibitor on Experimentally Induced Non-Alcoholic Fatty Liver Disease in Rats", The Medical Journal of Cairo University, doi:10.21608/mjcu.2018.55786, (20180301), pages 1065 - 1076, URL: https://mjcu.journals.ekb.eg/article_55786_9206f1f6d62d35b99b5249d78e64d36d.pdf, (20211109), XP055859552 [Y] 1-10 * title, abstract *
DOI: http://dx.doi.org/10.21608/mjcu.2018.55786
Cited inInternational search
Type:Patent literature
Publication No.:WO2004014916  [X]
 (WARNER LAMBERT CO [US], et al) [X] 1-3, 6-10;
Type:Patent literature
Publication No.:CN102311448  [X]
 (GUANGZHOU INST BIOMED & HEALTH, et al) [X] 1-9;
Type:Patent literature
Publication No.:CN102659813  [X]
 (SHANGHAI INST MATERIA MEDICA) [X] 1-9;
Type:Patent literature
Publication No.:CN103130819  [XY]
 (SHANGHAI INST MATERIA MEDICA) [X] 1-9 [Y] 1-10;
Type:Patent literature
Publication No.:CN107216340  [X]
 (SHANGHAI INST MATERIA MEDICA CAS)[X] 1-9;
Type:Non-patent literature
Publication information:[Y]  - YU, Yuan et al, "Progress of the Correlation between DPP-4 and Chronic Liver Disease", Chinese Journal of Gastroenterology and Hepatology, (20150930), vol. 24, no. 9, pages 1152 - 1154, XP055736030 [Y] 1-10